应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
02511 君圣泰医药-B
休市中 10-31 16:08:30
3.740
-0.120
-3.11%
最高
4.190
最低
3.690
成交量
151.00万
今开
3.980
昨收
3.860
日振幅
12.95%
总市值
21.36亿
流通市值
21.36亿
总股本
5.71亿
成交额
595.18万
换手率
0.26%
流通股本
5.71亿
市净率
6.20
ROE
-62.13%
每股收益
-0.92
52周最高
4.700
52周最低
0.870
市盈率
-4.06
股息
0.00
股息收益率
0.00
ROA
-35.29%
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
港股生物医药股盘中逆势走强!三生制药涨近10%,映恩生物-B涨超7%
老虎资讯综合 · 02:00
港股生物医药股盘中逆势走强!三生制药涨近10%,映恩生物-B涨超7%
君圣泰医药-B盘中异动 大幅上涨7.25%报4.140港元
市场透视 · 01:39
君圣泰医药-B盘中异动 大幅上涨7.25%报4.140港元
君圣泰医药-B(02511):全球首创抗炎代谢调节剂HTD1801完成2型糖尿病III期临床研究 展现持续52周的综合获益与安全性优势
智通财经 · 00:03
君圣泰医药-B(02511):全球首创抗炎代谢调节剂HTD1801完成2型糖尿病III期临床研究 展现持续52周的综合获益与安全性优势
君圣泰医药-B盘中异动 下午盘大幅下跌5.00%报3.610港元
市场透视 · 10-23
君圣泰医药-B盘中异动 下午盘大幅下跌5.00%报3.610港元
君圣泰医药-B盘中异动 快速拉升6.65%报3.530港元
市场透视 · 10-15
君圣泰医药-B盘中异动 快速拉升6.65%报3.530港元
君圣泰医药-B09月30日主力净流出45.2万元 散户资金买入
市场透视 · 09-30
君圣泰医药-B09月30日主力净流出45.2万元 散户资金买入
君圣泰医药-B盘中异动 下午盘急速下挫5.02%报3.970港元
市场透视 · 09-18
君圣泰医药-B盘中异动 下午盘急速下挫5.02%报3.970港元
君圣泰医药-B盘中异动 早盘股价大涨5.81%
市场透视 · 09-12
君圣泰医药-B盘中异动 早盘股价大涨5.81%
君圣泰医药-B盘中异动 股价大跌5.07%报4.120港元
市场透视 · 09-10
君圣泰医药-B盘中异动 股价大跌5.07%报4.120港元
君圣泰医药-B盘中异动 下午盘快速上涨5.14%
市场透视 · 09-03
君圣泰医药-B盘中异动 下午盘快速上涨5.14%
君圣泰医药-B09月01日主力净流入26.4万元 散户资金抛售
市场透视 · 09-01
君圣泰医药-B09月01日主力净流入26.4万元 散户资金抛售
港股异动 | 君圣泰医药-B(02511.HK)涨近8% 上半年亏损同比收窄42.96%
智通财经 · 08-26
港股异动 | 君圣泰医药-B(02511.HK)涨近8% 上半年亏损同比收窄42.96%
君圣泰医药中期亏损大幅收窄 核心产品HTD1801新增适应症慢性肾病
格隆汇 · 08-26
君圣泰医药中期亏损大幅收窄 核心产品HTD1801新增适应症慢性肾病
君圣泰医药-B(02511)发布中期业绩 股东应占亏损1.2亿元 同比收窄42.96%
智通财经 · 08-25
君圣泰医药-B(02511)发布中期业绩 股东应占亏损1.2亿元 同比收窄42.96%
君圣泰医药-B(02511)与中国医学科学院医药生物技术研究所共同开展课题合作 探索创新药代谢与肾脏获益潜力
智通财经 · 08-12
君圣泰医药-B(02511)与中国医学科学院医药生物技术研究所共同开展课题合作 探索创新药代谢与肾脏获益潜力
君圣泰医药-B08月11日主力净流出27.5万元 散户资金买入
市场透视 · 08-11
君圣泰医药-B08月11日主力净流出27.5万元 散户资金买入
君圣泰医药-B08月07日主力净流出60.8万元 散户资金买入
市场透视 · 08-07
君圣泰医药-B08月07日主力净流出60.8万元 散户资金买入
君圣泰医药-B盘中异动 急速拉升5.05%报3.330港元
市场透视 · 08-05
君圣泰医药-B盘中异动 急速拉升5.05%报3.330港元
君圣泰医药-B08月01日遭主力抛售182.4万元
市场透视 · 08-01
君圣泰医药-B08月01日遭主力抛售182.4万元
君圣泰医药-B盘中异动 股价大跌5.16%报3.310港元
市场透视 · 07-31
君圣泰医药-B盘中异动 股价大跌5.16%报3.310港元
加载更多
公司概况
公司名称:
君圣泰医药-B
所属市场:
SEHK
上市日期:
2023-12-22
主营业务:
君圣泰医药是一家生物制药公司,专注于就代谢及消化系统疾病的治疗发现、开发及商业化多功能及多靶点疗法。该公司自主开发了多个候选产品的产品管线,涵盖代谢和消化疾病的多种适应症,其中部分产品处于临床阶段。该公司的核心产品HTD1801(小檗碱熊去氧胆酸盐)是一种新分子实体,作为肠肝抗炎代谢调节剂,靶向调节对人体代谢过程中至关重要的多个通路,包括与代谢及消化系统疾病相关的通路。该公司在美国、中国大陆、香港和澳大利亚开展业务。
发行价格:
11.500
{"stockData":{"symbol":"02511","market":"HK","secType":"STK","nameCN":"君圣泰医药-B","latestPrice":3.74,"timestamp":1761898110960,"preClose":3.86,"halted":0,"volume":1510000,"delay":0,"floatShares":571000000,"shares":571000000,"eps":-0.9212826114327908,"marketStatus":"休市中","change":-0.12,"latestTime":"10-31 16:08:30","open":3.98,"high":4.19,"low":3.69,"amount":5951785,"amplitude":0.129534,"askPrice":3.79,"askSize":26000,"bidPrice":3.74,"bidSize":15500,"shortable":0,"etf":0,"ttmEps":-0.7025243542532935,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1762133400000},"marketStatusCode":7,"adr":0,"listingDate":1703174400000,"exchange":"SEHK","adjPreClose":3.86,"openAndCloseTimeList":[[1761874200000,1761883200000],[1761886800000,1761897600000]],"volumeRatio":4.575758,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02511","defaultTab":"news","newsList":[{"id":"1146762585","title":"港股生物医药股盘中逆势走强!三生制药涨近10%,映恩生物-B涨超7%","url":"https://stock-news.laohu8.com/highlight/detail?id=1146762585","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1146762585?lang=zh_cn&edition=full","pubTime":"2025-10-31 10:00","pubTimestamp":1761876007,"startTime":"0","endTime":"0","summary":"10月31日,港股生物医药股盘中逆势走强,$三生制药(01530)$涨近10%,$映恩生物-B(09606)$涨超7%,$百奥赛图-B(02315)$、$君圣泰医药-B(02511)$涨超6%,$信达生物(01801)$、$复宏汉霖(02696)$涨超4%。","market":"hk","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02315","09606","01530","02511","02696","09939","01801"],"gpt_icon":0},{"id":"2579492454","title":"君圣泰医药-B盘中异动 大幅上涨7.25%报4.140港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2579492454","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579492454?lang=zh_cn&edition=full","pubTime":"2025-10-31 09:39","pubTimestamp":1761874763,"startTime":"0","endTime":"0","summary":"2025年10月31日早盘09时39分,君圣泰医药-B股票出现异动,股价急速上涨7.25%。截至发稿,该股报4.140港元/股,成交量14.85万股,换手率0.03%,振幅4.66%。资金方面,该股资金流入43.6545万港元,流出4.5855万港元。君圣泰医药-B股票所在的药品行业中,整体跌幅为0.20%。其相关个股中,君圣泰医药-B、三生制药、三爱健康集团涨幅较大,振幅较大的相关个股有三生制药、君圣泰医药-B、信达生物,振幅分别为5.56%、4.66%、4.28%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251031093923a6d7bdf4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251031093923a6d7bdf4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02511","BK1161"],"gpt_icon":0},{"id":"2579107117","title":"君圣泰医药-B(02511):全球首创抗炎代谢调节剂HTD1801完成2型糖尿病III期临床研究 展现持续52周的综合获益与安全性优势","url":"https://stock-news.laohu8.com/highlight/detail?id=2579107117","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579107117?lang=zh_cn&edition=full","pubTime":"2025-10-31 08:03","pubTimestamp":1761869031,"startTime":"0","endTime":"0","summary":"智通财经APP讯,君圣泰医药-B 公布,HTD1801在2型糖尿病患者中开展的两项 III期临床试验已顺利完成,52周研究取得积极的疗效与安全性结果。两项III期临床研究的52周数据充分验证了HTD1801疗效的持久性,并进一步凸显其为T2DM患者带来的长期综合临床获益。HTD1801在长期治疗中展现出良好的安全性与耐受性,与双盲期结果保持一致。对于接受HTD1801治疗的患者,治疗期延长不会增加其不良事件的类型与严重程度。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1363425.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["III","02511","BK4134","BK1161"],"gpt_icon":0},{"id":"2577768673","title":"君圣泰医药-B盘中异动 下午盘大幅下跌5.00%报3.610港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2577768673","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577768673?lang=zh_cn&edition=full","pubTime":"2025-10-23 14:47","pubTimestamp":1761202027,"startTime":"0","endTime":"0","summary":"2025年10月23日下午盘14时47分,君圣泰医药-B股票出现波动,股价快速跳水5.00%。截至发稿,该股报3.610港元/股,成交量25.2万股,换手率0.04%,振幅3.95%。资金方面,该股资金流入15.275万港元,流出68.655万港元。君圣泰医药-B股票所在的药品行业中,整体跌幅为1.06%。其相关个股中,海西新药、劲方医药-B、兴科蓉医药涨幅较大,振幅较大的相关个股有劲方医药-B、德琪医药-B、海西新药,振幅分别为15.31%、14.43%、14.38%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025102314470794d929c4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025102314470794d929c4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02511","BK1161"],"gpt_icon":0},{"id":"2575523187","title":"君圣泰医药-B盘中异动 快速拉升6.65%报3.530港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2575523187","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2575523187?lang=zh_cn&edition=full","pubTime":"2025-10-15 10:09","pubTimestamp":1760494168,"startTime":"0","endTime":"0","summary":"2025年10月15日早盘10时09分,君圣泰医药-B股票出现波动,股价快速拉升6.65%。截至发稿,该股报3.530港元/股,成交量8万股,换手率0.01%,振幅7.85%。资金方面,该股资金流入17.2785万港元,流出7.707万港元。君圣泰医药-B股票所在的药品行业中,整体跌幅为0.14%。其相关个股中,君圣泰医药-B、三爱健康集团、康臣药业涨幅较大,振幅较大的相关个股有康臣药业、德琪医药-B、君圣泰医药-B,振幅分别为9.63%、7.43%、6.34%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251015100928a46086aa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251015100928a46086aa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02511"],"gpt_icon":0},{"id":"2572773293","title":"君圣泰医药-B09月30日主力净流出45.2万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2572773293","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2572773293?lang=zh_cn&edition=full","pubTime":"2025-09-30 16:15","pubTimestamp":1759220144,"startTime":"0","endTime":"0","summary":"09月30日, 君圣泰医药-B股价跌0.26%,报收3.84元,成交金额176.9万元,换手率0.08%,振幅3.12%,量比0.44。君圣泰医药-B今日主力资金净流出45.2万元,上一交易日主力净流出0万元。该股近5个交易日下跌6.57%,主力资金累计净流出16.9万元;近20日主力资金累计净流入23.9万元,其中净流入天数为6日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202509301620329719f6c8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202509301620329719f6c8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02511"],"gpt_icon":0},{"id":"2568424481","title":"君圣泰医药-B盘中异动 下午盘急速下挫5.02%报3.970港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2568424481","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2568424481?lang=zh_cn&edition=full","pubTime":"2025-09-18 14:40","pubTimestamp":1758177658,"startTime":"0","endTime":"0","summary":"2025年09月18日下午盘14时40分,君圣泰医药-B股票出现波动,股价快速下跌5.02%。截至发稿,该股报3.970港元/股,成交量210.55万股,换手率0.37%,振幅7.66%。资金方面,该股资金流入350.431万港元,流出474.665万港元。君圣泰医药-B股票所在的药品行业中,整体涨幅为0.41%。君圣泰医药-B公司简介:君圣泰医药是一家生物制药公司,专注于就代谢及消化系统疾病的治疗发现、开发及商业化多功能及多标靶疗法。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250918144058979a5ddc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250918144058979a5ddc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02511"],"gpt_icon":0},{"id":"2566929717","title":"君圣泰医药-B盘中异动 早盘股价大涨5.81%","url":"https://stock-news.laohu8.com/highlight/detail?id=2566929717","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2566929717?lang=zh_cn&edition=full","pubTime":"2025-09-12 09:36","pubTimestamp":1757640969,"startTime":"0","endTime":"0","summary":"2025年09月12日早盘09时36分,君圣泰医药-B股票出现异动,股价急速上涨5.81%。君圣泰医药-B股票所在的药品行业中,整体涨幅为0.52%。其相关个股中,君圣泰医药-B、德琪医药-B、东阳光药涨幅较大,振幅较大的相关个股有君圣泰医药-B、凯莱英、复星医药,振幅分别为6.54%、4.63%、4.21%。君圣泰医药-B公司简介:君圣泰医药是一家生物制药公司,专注于就代谢及消化系统疾病的治疗发现、开发及商业化多功能及多标靶疗法。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250912093609978ba3b1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250912093609978ba3b1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02511"],"gpt_icon":0},{"id":"2566626446","title":"君圣泰医药-B盘中异动 股价大跌5.07%报4.120港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2566626446","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2566626446?lang=zh_cn&edition=full","pubTime":"2025-09-10 10:17","pubTimestamp":1757470638,"startTime":"0","endTime":"0","summary":"2025年09月10日早盘10时17分,君圣泰医药-B股票出现波动,股价急速跳水5.07%。截至发稿,该股报4.120港元/股,成交量72.55万股,换手率0.13%,振幅6.22%。资金方面,该股资金流入91.634万港元,流出200.4万港元。君圣泰医药-B股票所在的药品行业中,整体涨幅为0.04%。其相关个股中,泰凌医药、兴科蓉医药、励晶太平洋涨幅较大,振幅较大的相关个股有康龙化成、兴科蓉医药、三生制药,振幅分别为7.11%、6.87%、6.41%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250910101718a4bfda94&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250910101718a4bfda94&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02511"],"gpt_icon":0},{"id":"2564638123","title":"君圣泰医药-B盘中异动 下午盘快速上涨5.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2564638123","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2564638123?lang=zh_cn&edition=full","pubTime":"2025-09-03 13:33","pubTimestamp":1756877616,"startTime":"0","endTime":"0","summary":"2025年09月03日下午盘13时33分,君圣泰医药-B股票出现波动,股价急速上涨5.14%。君圣泰医药-B股票所在的药品行业中,整体涨幅为2.09%。其相关个股中,德琪医药-B、四环医药、恒瑞医药涨幅较大,振幅较大的相关个股有衍生集团、李氏大药厂、四环医药,振幅分别为19.28%、9.81%、8.67%。君圣泰医药-B公司简介:君圣泰医药是一家生物制药公司,专注于就代谢及消化系统疾病的治疗发现、开发及商业化多功能及多标靶疗法。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250903133336a70ce43b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250903133336a70ce43b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02511"],"gpt_icon":0},{"id":"2564414958","title":"君圣泰医药-B09月01日主力净流入26.4万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2564414958","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2564414958?lang=zh_cn&edition=full","pubTime":"2025-09-01 16:15","pubTimestamp":1756714553,"startTime":"0","endTime":"0","summary":"09月01日, 君圣泰医药-B股价涨0.29%,报收3.42元,成交金额357.7万元,换手率0.18%,振幅9.97%,量比0.90。君圣泰医药-B今日主力资金净流入26.4万元,上一交易日主力净流出0万元。该股近5个交易日上涨8.57%,主力资金累计净流出134.8万元;近20日主力资金累计净流出605.1万元,其中净流出天数为8日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250901171613a70913af&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250901171613a70913af&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02511","BK1161"],"gpt_icon":0},{"id":"2562207008","title":"港股异动 | 君圣泰医药-B(02511.HK)涨近8% 上半年亏损同比收窄42.96%","url":"https://stock-news.laohu8.com/highlight/detail?id=2562207008","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2562207008?lang=zh_cn&edition=full","pubTime":"2025-08-26 14:47","pubTimestamp":1756190833,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1161","02511"],"gpt_icon":0},{"id":"2562205392","title":"君圣泰医药中期亏损大幅收窄 核心产品HTD1801新增适应症慢性肾病","url":"https://stock-news.laohu8.com/highlight/detail?id=2562205392","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2562205392?lang=zh_cn&edition=full","pubTime":"2025-08-26 11:25","pubTimestamp":1756178745,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["DM0.SI","BK1161","BK7095","BK6053","PSC","02511","PSC.AU"],"gpt_icon":0},{"id":"2562211723","title":"君圣泰医药-B(02511)发布中期业绩 股东应占亏损1.2亿元 同比收窄42.96%","url":"https://stock-news.laohu8.com/highlight/detail?id=2562211723","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2562211723?lang=zh_cn&edition=full","pubTime":"2025-08-25 16:34","pubTimestamp":1756110844,"startTime":"0","endTime":"0","summary":"智通财经APP讯,君圣泰医药-B(02511)发布截至2025年6月30日止六个月的中期业绩,其他收入1054.2万元(人民币,下同),同比减少69.96%;股东应占亏损1.2亿元,同比收窄42.96%;每股基本亏损0.27元。公告称,其他收入减少乃主要由于政府补助减少约1910万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1334439.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","02511"],"gpt_icon":0},{"id":"2558649965","title":"君圣泰医药-B(02511)与中国医学科学院医药生物技术研究所共同开展课题合作 探索创新药代谢与肾脏获益潜力","url":"https://stock-news.laohu8.com/highlight/detail?id=2558649965","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558649965?lang=zh_cn&edition=full","pubTime":"2025-08-12 18:59","pubTimestamp":1754996384,"startTime":"0","endTime":"0","summary":"智通财经APP讯,君圣泰医药-B 公布,集团的全资附属公司深圳君圣泰生物技术有限公司与中国医学科学院医药生物技术研究所(药生所)共同开展课题合作,评估集团核心产品HTD1801对糖尿病伴慢性肾病的治疗潜力。该项目已于近日在中国医学科学院完成课题批准。基于本项目,双方将围绕糖尿病及伴慢性肾病适应症共同开展创新药物的机制和临床研究,致力于探索具备综合干预价值的创新治疗方案。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1328665.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["163118","000808.SH","BK1161","02511","BK1574","06978","159992"],"gpt_icon":0},{"id":"2558656624","title":"君圣泰医药-B08月11日主力净流出27.5万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2558656624","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558656624?lang=zh_cn&edition=full","pubTime":"2025-08-11 16:15","pubTimestamp":1754900114,"startTime":"0","endTime":"0","summary":"08月11日, 君圣泰医药-B股价跌1.25%,报收3.17元,成交金额257.4万元,换手率0.14%,振幅5.92%,量比1.05。君圣泰医药-B今日主力资金净流出27.5万元,上一交易日主力净流出0万元。|08月11日主力加仓幅度排名||#|股票简称|主力净额占比|#|嘉鼎国际集团|5.27%|#|PACIFICLEGEND|2.30%|#|龙蟠科技|2.15%|#|...|...|#2428|君圣泰医药-B|-0.02%|(以上内容为腾讯自选股基于公开消息,由程序或算法智能生成,仅作为用户看盘参考,不作为投资建议或交易依据。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250811164939a4819eae&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250811164939a4819eae&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02511","BK1161"],"gpt_icon":0},{"id":"2557550688","title":"君圣泰医药-B08月07日主力净流出60.8万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2557550688","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557550688?lang=zh_cn&edition=full","pubTime":"2025-08-07 16:15","pubTimestamp":1754554553,"startTime":"0","endTime":"0","summary":"08月07日, 君圣泰医药-B股价跌1.54%,报收3.20元,成交金额308.6万元,换手率0.17%,振幅3.08%,量比0.73。君圣泰医药-B今日主力资金净流出60.8万元,上一交易日主力净流入68.2万元。该股近5个交易日下跌2.74%,主力资金累计净流出175.1万元;近20日主力资金累计净流出664.5万元,其中净流出天数为11日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250807172054a47a9a16&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250807172054a47a9a16&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02511","BK1161"],"gpt_icon":0},{"id":"2557337399","title":"君圣泰医药-B盘中异动 急速拉升5.05%报3.330港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2557337399","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557337399?lang=zh_cn&edition=full","pubTime":"2025-08-05 15:49","pubTimestamp":1754380161,"startTime":"0","endTime":"0","summary":"2025年08月05日临近收盘15时49分,君圣泰医药-B股票出现异动,股价急速拉升5.05%。截至发稿,该股报3.330港元/股,成交量72.6万股,换手率0.13%,振幅5.68%。君圣泰医药-B股票所在的药品行业中,整体涨幅为1.36%。其相关个股中,兆科眼科-B、德琪医药-B、艾美疫苗涨幅较大,振幅较大的相关个股有兆科眼科-B、开拓药业-B、艾美疫苗,振幅分别为12.54%、10.05%、9.70%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202508051549219734c514&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202508051549219734c514&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02511"],"gpt_icon":0},{"id":"2556899397","title":"君圣泰医药-B08月01日遭主力抛售182.4万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2556899397","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2556899397?lang=zh_cn&edition=full","pubTime":"2025-08-01 16:15","pubTimestamp":1754036156,"startTime":"0","endTime":"0","summary":"08月01日, 君圣泰医药-B股价跌6.38%,报收3.08元,成交金额819.7万元,换手率0.46%,振幅6.08%,量比0.97。君圣泰医药-B今日主力资金净流出182.4万元,连续3日净流出,上一交易日主力净流出106.6万元。该股近5个交易日下跌13.24%,主力资金累计净流出303.1万元;近20日主力资金累计净流出435.0万元,其中净流出天数为12日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250801165855a46f60de&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250801165855a46f60de&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02511"],"gpt_icon":0},{"id":"2555097410","title":"君圣泰医药-B盘中异动 股价大跌5.16%报3.310港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2555097410","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555097410?lang=zh_cn&edition=full","pubTime":"2025-07-31 14:08","pubTimestamp":1753942117,"startTime":"0","endTime":"0","summary":"2025年07月31日下午盘14时08分,君圣泰医药-B股票出现异动,股价大幅下跌5.16%。截至发稿,该股报3.310港元/股,成交量100.05万股,换手率0.18%,振幅6.59%。资金方面,该股资金流入36.837万港元,流出270.608万港元。君圣泰医药-B股票所在的药品行业中,整体跌幅为0.62%。其相关个股中,李氏大药厂、泰凌医药、联康生物科技集团涨幅较大,振幅较大的相关个股有泰凌医药、李氏大药厂、中国同辐,振幅分别为26.32%、23.08%、9.38%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250731140837972962a0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250731140837972962a0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02511"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.hightidetx.com","stockEarnings":[{"period":"1week","weight":0.0136},{"period":"1month","weight":-0.026},{"period":"3month","weight":0.2143},{"period":"6month","weight":1.0778},{"period":"1year","weight":2.1695},{"period":"ytd","weight":1.9449}],"compareEarnings":[{"period":"1week","weight":-0.0097},{"period":"1month","weight":-0.0353},{"period":"3month","weight":0.0571},{"period":"6month","weight":0.1512},{"period":"1year","weight":0.2751},{"period":"ytd","weight":0.2915}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"君圣泰医药是一家生物制药公司,专注于就代谢及消化系统疾病的治疗发现、开发及商业化多功能及多靶点疗法。该公司自主开发了多个候选产品的产品管线,涵盖代谢和消化疾病的多种适应症,其中部分产品处于临床阶段。该公司的核心产品HTD1801(小檗碱熊去氧胆酸盐)是一种新分子实体,作为肠肝抗炎代谢调节剂,靶向调节对人体代谢过程中至关重要的多个通路,包括与代谢及消化系统疾病相关的通路。该公司在美国、中国大陆、香港和澳大利亚开展业务。","exchange":"SEHK","name":"君圣泰医药-B","nameEN":"HIGHTIDE-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.5","shortVersion":"4.35.5","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"君圣泰医药-B(02511)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供君圣泰医药-B(02511)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"君圣泰医药-B,02511,君圣泰医药-B股票,君圣泰医药-B股票老虎,君圣泰医药-B股票老虎国际,君圣泰医药-B行情,君圣泰医药-B股票行情,君圣泰医药-B股价,君圣泰医药-B股市,君圣泰医药-B股票价格,君圣泰医药-B股票交易,君圣泰医药-B股票购买,君圣泰医药-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"君圣泰医药-B(02511)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供君圣泰医药-B(02511)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}